Eng, C., Ciombor, K. K., Cho, M., Dorth, J. A., Rajdev, L. N., Horowitz, D. P., Gollub, M. J., Jácome, A. A., Lockney, N. A., Muldoon, R. L., Washington, M. K., O’Brian, B. A., Benny, A., Lebeck Lee, C. M., Benson, A. B., Goodman, K. A., & Morris, V. K. (2022). Anal Cancer: Emerging Standards in a Rare Disease. Journal of Clinical Oncology, 40(24), 2774–2788. https://doi.org/10.1200/jco.21.02566

Kwan, M. L., Cheng, R. K., Iribarren, C., Neugebauer, R., Rana, J. S., Nguyen-Huynh, M., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Shen, H., Rillamas-Sun, E., Santiago-Torres, M., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2022). Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study. Journal of Clinical Oncology, 40(15), 1635–1646. https://doi.org/10.1200/jco.21.01738

Greenlee, H., Iribarren, C., Rana, J. S., Cheng, R., Nguyen-Huynh, M., Rillamas-Sun, E., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Santiago-Torres, M., Shen, H., Hershman, D. L., Kushi, L. H., Neugebauer, R., & Kwan, M. L. (2022). Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. Journal of Clinical Oncology, 40(15), 1647–1658. https://doi.org/10.1200/jco.21.01736

Korde, L. A., Somerfield, M. R., & Hershman, D. L. (2022). Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology, 40(15), 1696–1698. https://doi.org/10.1200/jco.22.00503

Li, S., Silvestri, V., Leslie, G., Rebbeck, T. R., Neuhausen, S. L., Hopper, J. L., Nielsen, H. R., Lee, A., Yang, X., McGuffog, L., Parsons, M. T., Andrulis, I. L., Arnold, N., Belotti, M., Borg, Å., Buecher, B., Buys, S. S., Caputo, S. M., Chung, W. K., … Antoniou, A. C. (2022). Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. Journal of Clinical Oncology, 40(14), 1529–1541. https://doi.org/10.1200/jco.21.02112

Schultz, L. M., Baggott, C., Prabhu, S., Pacenta, H. L., Phillips, C. L., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., Satwani, P., Krupski, C., Keating, A. K., … Laetsch, T. W. (2022). Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report. Journal of Clinical Oncology, 40(9), 945–955. https://doi.org/10.1200/jco.20.03585

Vogelbaum, M. A., Brown, P. D., Messersmith, H., Brastianos, P. K., Burri, S., Cahill, D., Dunn, I. F., Gaspar, L. E., Gatson, N. T. N., Gondi, V., Jordan, J. T., Lassman, A. B., Maues, J., Mohile, N., Redjal, N., Stevens, G., Sulman, E., van den Bent, M., Wallace, H. J., … Schiff, D. (2022). Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. Journal of Clinical Oncology, 40(5), 492–516. https://doi.org/10.1200/jco.21.02314

Barton, D. L., Pugh, S. L., Ganz, P. A., Plaxe, S. C., Koontz, B. F., Carter, J., Greyz-Yusupov, N., Page, S. J., Rowland, K. M., Balcueva, E. P., Nabeel, S., Basil, J. B., Hill, M. L., Muller, C. Y., Bell, M. C., Deshmukh, S., & Kachnic, L. A. (2022). Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004. Journal of Clinical Oncology, 40(4), 324–334. https://doi.org/10.1200/jco.21.01473